Amin
Analyst
Jefferies
Equibles does not estimate personal net worth.
About Amin
Amin is recorded as Analyst at Jefferies. Amin has spoken on 2 earnings calls across 1 company, most recently for Rigel Pharmaceuticals Inc on August 4, 2026. The companies whose calls Amin spoke on are classified in the Healthcare sector.
Amin on recent calls
“First, you increased the upper bound of guidance by $5 million, which doesn't include Vepanu. So the question is, what are you seeing to date for the commercial portfolio that are underpinning this assumption?”
“For Gavrido Revenue, it seems like that it's plateauing in one queue. What has been the feedback from the sales team and prescribers? Any color on new patient starts versus switches?”
Affiliation history
-
Jefferies
Analyst
Transcript header (unverified)
Current